Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Frequently asked questions
What sector does Eton Pharmaceuticals Inc (ETON) operate in?
Eton Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Eton Pharmaceuticals Inc (ETON) current stock price?
As of the latest data, Eton Pharmaceuticals Inc stock price is $55.50, with a previous close of $57.07. Eton Pharmaceuticals Inc lost -$1.57 in the last trading session, representing a -2.75% loss.
What is Eton Pharmaceuticals Inc (ETON) current market capitalization?
Eton Pharmaceuticals Inc market cap is approximately 1.59 billion.
What is Eton Pharmaceuticals Inc (ETON) Earnings Per Share (EPS)?
The trailing EPS is $0.37, and the forward EPS is $2.58.
What is Eton Pharmaceuticals Inc (ETON) Price-to-Earnings (P/E) ratio?
Eton Pharmaceuticals Inc current P/E ratio is 150, with a forward P/E of 21.51.
What is Eton Pharmaceuticals Inc (ETON) EBITDA?
Eton Pharmaceuticals Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 12.79 million.
Does Eton Pharmaceuticals Inc (ETON) pay dividends?
No. Eton Pharmaceuticals Inc does not pay a dividend.
How did Eton Pharmaceuticals Inc (ETON) perform in its most recent earnings report?
In the last report (June 30, 2026), Eton Pharmaceuticals Inc posted an EPS surprise of 218.18% and a revenue surprise of 38.61%.
When is Eton Pharmaceuticals Inc (ETON) next earnings report?
Eton Pharmaceuticals Inc is expected to release its next earnings report on September 30, 2026.
What is Eton Pharmaceuticals Inc (ETON) beta (volatility) score?
Eton Pharmaceuticals Inc has a beta of 0.900, meaning its volatility is roughly in line with the market.
